proadifen has been researched along with Experimental Mammary Neoplasms in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greiner, JW | 1 |
| Bryan, AH | 1 |
| Malan-Shibley, LB | 1 |
| Janss, DH | 1 |
| Wheatley, DN | 1 |
2 other studies available for proadifen and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Aryl hydrocarbon hydroxylase and epoxide hydratase activities: age effects in mammary epithelial cells of Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Age Factors; Animals; Aryl Hydrocarbon Hydroxylase | 1980 |
Enhancement and inhibition of the induction by 7,12-dimethylbenz(a)anthracene of mammary tumours in female Sprague-Dawley rats.
Topics: Adenocarcinoma; Adenofibroma; Adenoma; Animals; Anthracenes; Benz(a)Anthracenes; Fibroma; Mammary Ne | 1968 |